Abstract

Esophageal sclerosis is the most common visceral manifestation of systemic sclerosis, resulting in impaired esophageal clearance and retention of ingested food; in addition, co-existence of lung fibrosis with esophageal scleroderma is not uncommon. Both the progression of generalized connective tissue disorders and the damaging effect of chronic aspiration due to esophageal dysmotility appear to be involved in this procedure of interstitial fibrosis. Nifedipine is a widely prescribed calcium antagonist in a significant percentage of rheumatologic patients suffering from Raynaud syndrome, in order to inhibit peripheral vasospasm. Nevertheless, blocking calcium channels has proven to contribute to exacerbation of gastroesophageal reflux, which consequently can lead to chronic aspiration. We describe the case of severe exacerbation of interstitial lung disease in a 76-year-old female with esophageal sclerosis who was treated with oral nifedipine for Raynaud syndrome.

Links

PMC Free PDF

PMC Free Full Text

Publisher Full Text

Publisher Full Text

Authors

Seretis C, Seretis F, Gemenetzis G, Liakos N, Pappas A, Gourgiotis S, Lagoudianakis E, Keramidaris D, Salemis N

Institution

2nd Department of Surgery, 401 General Army Hospital of Athens, Athens, Argos, Greece.

Source

Case reports in gastroenterology 6:1 2012 Jan pg 82-7

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22423244